サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1318948

毒物学的薬物スクリーニング市場：製品、検査、用途別-2023-2030年の世界予測

Toxicology Drug Screening Market by Product, Testing, Application - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 190 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
毒物学的薬物スクリーニング市場：製品、検査、用途別-2023-2030年の世界予測
出版日: 2023年06月12日
発行: 360iResearch
ページ情報: 英文 190 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

毒物学的薬物スクリーニングの世界市場は、2023年に270億7,000万米ドル、CAGR13.31%で大幅な成長が予測され、2030年には652億2,000万米ドルに達すると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界の毒物学的薬物スクリーニング市場を評価するために不可欠です。事業戦略と製品満足度の主要指標を調査することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.毒物学的薬物スクリーニングの世界市場規模および予測は？

2.予測期間中、世界の毒物学的薬物スクリーニング市場を形成するCOVID-19の阻害要因と影響は？

3.毒物学的薬物スクリーニングの世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は？

4.毒物学的薬物スクリーニングの世界市場における競争戦略は？

5.毒物学的薬物スクリーニングの世界市場における技術動向と規制の枠組みは？

6.毒物学的薬物スクリーニングの世界市場における主要ベンダーの市場シェアは？

7.毒物学的薬物スクリーニングの世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 職場での薬物検査の実施とポイントオブケア検査（POCT）装置の普及率の向上
      • ハイエンドの薬物スクリーニング機器、試薬、キットの入手可能性の拡大
      • 毒性試験に対する政府支出の増加
    • 抑制要因
      • 毒物学的薬物スクリーニングテストのコストが高い
    • 機会
      • 高度な毒物学的薬物スクリーニングテストのイントロダクション
      • 食品・飲料業界および化学業界での毒物学的薬物スクリーニングの採用の増加
    • 課題
      • 毒物学的薬物スクリーニングに関連するサンプルテストにかかる時間が長くなる
  • 市場動向
  • COVID-19の累積的な影響
  • ロシア・ウクライナ紛争の累積的影響
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み
  • 顧客のカスタマイズ

第6章 毒物学的薬物スクリーニング市場：製品別

  • 動物モデル
  • 楽器
  • 試薬と消耗品
  • ソフトウェア

第7章 毒物学的薬物スクリーニング市場テスト別

  • インシリコ
  • In vitro（体外）
  • In vivo

第8章 毒物学的薬物スクリーニング市場：用途別

  • 発生および生殖毒性
  • 内分泌かく乱
  • 免疫毒性
  • 全身毒性

第9章 南北アメリカの毒物学的薬物スクリーニング市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋地域の毒物学的薬物スクリーニング市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第11章 欧州・中東・アフリカの毒物学的薬物スクリーニング市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ分析：主要企業別

第13章 掲載企業一覧

第14章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. TOXICOLOGY DRUG SCREENING MARKET RESEARCH PROCESS
  • FIGURE 2. TOXICOLOGY DRUG SCREENING MARKET SIZE, 2022 VS 2030
  • FIGURE 3. TOXICOLOGY DRUG SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
  • FIGURE 5. TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2022 VS 2030 (%)
  • FIGURE 6. TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 7. TOXICOLOGY DRUG SCREENING MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 8. TOXICOLOGY DRUG SCREENING MARKET DYNAMICS
  • FIGURE 9. TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. EUROPE, MIDDLE EAST & AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. TOXICOLOGY DRUG SCREENING MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 17. TOXICOLOGY DRUG SCREENING MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. TOXICOLOGY DRUG SCREENING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. TOXICOLOGY DRUG SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 5. TOXICOLOGY DRUG SCREENING MARKET SIZE, BY ANIMAL MODELS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. TOXICOLOGY DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. TOXICOLOGY DRUG SCREENING MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 10. TOXICOLOGY DRUG SCREENING MARKET SIZE, BY IN SILICO, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. TOXICOLOGY DRUG SCREENING MARKET SIZE, BY IN VITRO, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. TOXICOLOGY DRUG SCREENING MARKET SIZE, BY IN VIVO, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 14. TOXICOLOGY DRUG SCREENING MARKET SIZE, BY DEVELOPMENTAL & REPRODUCTIVE TOXICITY , BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. TOXICOLOGY DRUG SCREENING MARKET SIZE, BY ENDOCRINE DISRUPTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. TOXICOLOGY DRUG SCREENING MARKET SIZE, BY IMMUNOTOXICITY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SYSTEMICTOXICITY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. TOXICOLOGY DRUG SCREENING MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 146. TOXICOLOGY DRUG SCREENING MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 147. TOXICOLOGY DRUG SCREENING MARKET LICENSE & PRICING
目次
Product Code: MRR-AD517FAA7DBA

The Global Toxicology Drug Screening Market is forecasted to grow significantly, with a projected USD 27.07 billion in 2023 at a CAGR of 13.31% and expected to reach a staggering USD 65.22 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Toxicology Drug Screening Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Toxicology Drug Screening Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across Animal Models, Instruments, Reagents & Consumables, and Software. The Animal Models is projected to witness significant market share during forecast period.

Based on Testing, market is studied across In Silico, In Vitro, and In Vivo. The In Silico is projected to witness significant market share during forecast period.

Based on Application, market is studied across Developmental & Reproductive Toxicity, Endocrine Disruption, Immunotoxicity, and Systemictoxicity. The Endocrine Disruption is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa is projected to witness significant market share during forecast period.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Toxicology Drug Screening Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Toxicology Drug Screening Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Toxicology Drug Screening Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Toxicology Drug Screening Market?

4. What is the competitive strategic window for opportunities in the Global Toxicology Drug Screening Market?

5. What are the technology trends and regulatory frameworks in the Global Toxicology Drug Screening Market?

6. What is the market share of the leading vendors in the Global Toxicology Drug Screening Market?

7. What modes and strategic moves are considered suitable for entering the Global Toxicology Drug Screening Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Toxicology Drug Screening Market, by Product, 2022 vs 2030
  • 4.3. Toxicology Drug Screening Market, by Testing, 2022 vs 2030
  • 4.4. Toxicology Drug Screening Market, by Application, 2022 vs 2030
  • 4.5. Toxicology Drug Screening Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing practice of workplace drug testing and high penetration of point of care testing (POCT) devices
      • 5.1.1.2. Growing availability of high-end drug screening instruments, reagent and kits
      • 5.1.1.3. Rising government expenditure on toxicity testing
    • 5.1.2. Restraints
      • 5.1.2.1. High Cost of toxicology drug screening tests
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of advanced toxicology drug screening tests
      • 5.1.3.2. Rise in adoption of toxicology drug screening in the food and beverage industry, and chemical industry
    • 5.1.4. Challenges
      • 5.1.4.1. Longer time for sample testing associated with toxicology drug screening
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Toxicology Drug Screening Market, by Product

  • 6.1. Introduction
  • 6.2. Animal Models
  • 6.3. Instruments
  • 6.4. Reagents & Consumables
  • 6.5. Software

7. Toxicology Drug Screening Market, by Testing

  • 7.1. Introduction
  • 7.2. In Silico
  • 7.3. In Vitro
  • 7.4. In Vivo

8. Toxicology Drug Screening Market, by Application

  • 8.1. Introduction
  • 8.2. Developmental & Reproductive Toxicity
  • 8.3. Endocrine Disruption
  • 8.4. Immunotoxicity
  • 8.5. Systemictoxicity

9. Americas Toxicology Drug Screening Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Toxicology Drug Screening Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Toxicology Drug Screening Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing